Nisaurrahmah, N.; Sri, O.; Ifora, I. Efficacy and Safety of 5-Hydroxytryptamine-3 Receptor Antagonists (5-HT3 RAs) for The Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: A Review. J. Drug Delivery Ther. 2021, 11 (1-s), 195-199. https://doi.org/10.22270/jddt.v11i1-s.4554.